ADIPOQ and cystic fibrosis: In conclusion, although a causal relationship between attenuated FEV1% decline and decreased adiponectin and TNFα levels has not been clearly proven, this study demonstrated that PA may represent a useful complementary strategy in the management of CF patients and that these cytokines are valuable as blood markers of inflammation.